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Dias, Ana Carolina Rodrigues, Eduardo Colombari,
and Steven W. Mifflin. Effect of nitric oxide on excitatory
amino acid-evoked discharge of neurons in NTS. Am J
Physiol Heart Circ Physiol 284: H234–H240, 2003; 10.1152/
ajpheart.00037.2002.—N-methyl-D-aspartate (NMDA) and
non-NMDA excitatory amino acid (EAA) receptor subtypes
are involved in the integration of visceral afferent inputs
within the nucleus of the solitary tract (NTS). Microinjection
studies indicate interactions between nitric oxide (NO) and
EAA receptors within the NTS. To examine these interac-
tions at the single cell level, this study characterized the
effects of the NO synthase inhibitor NG-nitro-L-arginine
methyl ester (L-NAME) and the NO donor 3-[2-hydroxy-2-
nitroso-1-propylhydrazino]-1-propanamine (PAPA-NONOate)
on the excitatory responses of vagus nerve (VN)-evoked NTS
neurons to the activation of (RS)--amino-3-hydroxy-5-
methyl-4-isoxazolepropionic acid (AMPA) and NMDA recep-
tors in rats. Iontophoresis of L-NAME did not alter sponta-
neous or VN-evoked discharges, but significantly decreased
the number of action potentials (APs) evoked by ionto-
phoretic application of AMPA. The effects of L-NAME on
NMDA-evoked discharge were variable; for the population,
L-NAME did not change the number of APs evoked by
NMDA. PAPA-NONOate enhanced the spontaneous dis-
charge and the number of APs elicited by AMPA but not
NMDA. Iontophoresis of the inactive enantiomers NG-nitro-
D-arginine methyl ester and hydroxydiazenesulfonic acid
1-oxide disodium salt had no effect on AMPA-evoked dis-
charge. Our data suggest that NO facilitates AMPA-medi-
ated neuronal transmission within the NTS.
nucleus of the solitary tract; N-methyl-D-aspartate; (RS)--
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid; vagus
nerve stimulation
IN VIVO AND IN VITRO STUDIES report that the activation of
glutamatergic receptors in the central nervous system
increases the production and release of nitrosothiol
substances (9, 29, 42). Nitric oxide (NO) is an unstable
radical that undergoes either nitrosation chemistry or
reaction with superoxide (14, 32, 39). The product of
these reactions can affect modulatory sites on excita-
tory amino acid (EAA) receptors and alter neuronal
responses to activation of these receptors (11, 17, 28,
32, 39, 40).
NO modulation of EAA responses can result in facil-
itation or inhibition depending on the specific brain
area affected. NO facilitates responses to EAAs within
the hippocampus (12, 13), the lateral geniculate nu-
cleus (5), and the ventrobasal thalamus (37), to provide
a few examples. In other areas, such as the cerebellum
(38) and the periaqueductal grey (24), NO appears to
mediate or facilitate inhibition. In certain areas, NO
modulation of EAA receptors is even more complicated:
in the dorsal horn of the spinal cord, inhibition of NO
synthase (NOS) attenuates N-methyl-D-aspartate
(NMDA) responses and facilitates (RS)--amino-3-
hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
responses (2).
The first synapses within the central nervous system
for the visceral afferent fibers of the vagus nerve (VN)
occur in the nucleus of the solitary tract (NTS). Nu-
merous studies have reported that these afferent ter-
minals release L-glutamate and NO among other neu-
rotransmitters (7, 10, 21). Vagal afferents to the NTS
contain NOS (16, 21), and vagal deafferentation de-
creases NOS immunoreactivity in the NTS (25). Immu-
nohistochemical approaches have demonstrated the co-
localization of neuronal NOS (nNOS) and the NMDA
receptor subunit NMDAR1 as well as the AMPA recep-
tor subunit GLuR1 in single neurons in the NTS of rats
(22). NOS immunoreactivity has also been found in
neurons in many nuclei within the medulla oblongata
that send projections to the NTS, which suggests that
NO generated in the NTS may modulate vagal afferent
integration (7). Therefore, sources of NO within the
NTS are peripheral afferent inputs to the nucleus, local
interneurons within the NTS, and inputs from other
central sites to the NTS.
Physiological studies also suggest a role for NO
within the NTS in the modulation of cardiovascular
function. Microdialysis and microinjection studies
have shown that NOS inhibitors reduce extracellular
levels of glutamate (19) and the cardiovascular re-
sponses to NTS microinjection of ionotropic EAA ago-
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nists (20, 30). Activation of cardiopulmonary afferent
inputs results in the release of NO, which activates
soluble guanylate cyclase within the NTS (18). Micro-
injection of soluble guanylate cyclase inhibitors into
the NTS reduces the cardiovascular responses to mi-
croinjection of ionotropic EAA agonists into the NTS
(42). Single unit recording studies from NTS neurons
indicate that NOS inhibitors decrease spontaneous dis-
charge (26) and NO donors increase spontaneous dis-
charge.
All of these results suggest that NO may modulate
visceral afferent integration within the NTS by modu-
lating neuronal responses to EAA receptor activation.
The specific aim of this study was to use single unit
recording and iontophoretic techniques to examine the
modulation by NO of NMDA- and AMPA-evoked dis-
charges in VN-evoked NTS neurons.
MATERIALS AND METHODS
Animals. Experiments were performed on Sprague-Daw-
ley rats (300–400 g body wt; Charles River). Rats were
housed two per cage in a laboratory animal room and had
unrestricted access to food and water. All animals were given
at least 1 wk to acclimate to the environment before use. All
experimental protocols were approved by the Institutional
Animal Care and Use Committee.
Preparation. Animals were anesthetized with Inactin (100
mg/kg ip; Sigma) and placed on a thermostatically controlled
heating pad. The trachea was cannulated and the rat was
artificially ventilated with room air supplemented with 100%
O2. The cervical VN including the aortic and laryngeal
branches ipsilateral to the site of central recording was
isolated and marked with a small loop of black suture. Cath-
eters were placed in the femoral artery and vein for blood
pressure monitoring and injection of drugs. Arterial pressure
was measured using a Cobe CDX transducer (Cobe Labora-
tories; Lakewood, CO). Mean arterial pressure (in mmHg)
and heart rate (in beats/min) were determined from the
pulsatile signal using a Coulbourn blood pressure processor.
Gallamine thiethiodide (20 mg/kg initially supplemented
with 5 mg as needed, typically every hour) was also given for
paralysis. Depth of anesthesia was gauged by the stability of
blood pressure and heart rate and the absence of a pressor
response to paw pinch. The rat was placed in a stereotaxic
frame, and an occipital craniotomy was performed to expose
the dorsal surface of the medulla in the region of obex. The
previously isolated VN was placed on bipolar stimulating
electrodes and covered with a mixture of mineral oil and
Vaseline petroleum jelly.
Electrophysiological recordings. Extracellular action po-
tential (AP) discharge was recorded with a five-barreled
electrode. The recording barrel was filled with a solution of
0.5 M sodium acetate that contained 2% Chicago sky blue.
One barrel of each five-barrel electrode was filled with a
solution of 3 M NaCl and used for current balancing and pH
controls. The other barrels were filled with different drug
solutions (see Drugs and drug administration). Recordings
were obtained from the region 1.2 mm caudal and 0.5 mm
rostral to the calamus scriptorius, 0–0.8 mm lateral to the
midline, and 0.2–1 mm below the surface. The electrode was
lowered into the tissue in 2.0-m steps by a step-driver
controller (Burleigh Instruments; Fisher, NY). The VN was
stimulated with single pulses of 1 ms in duration, 0.5 Hz, and
500 A. If the neuron responded with an AP to each of two
VN stimuli separated by 5 ms, the input was considered
monosynaptic; otherwise, the input was considered polysyn-
aptic.
APs were recorded and amplified by a direct current am-
plifier (World Precision Instruments; New Haven, CT)
passed through an alternating current filter and sent to a
digital oscilloscope (Nicolet Instruments; Madison, WI), an
audiomonitor (Grass Instruments; Quincy, MA), a videotape
recorder (A. R. Vetter; Rederburg, PA), and a window dis-
criminator (World Precision Instruments; Sarasota, FL). The
window-discriminator output was led to a Cambridge Elec-
tronic Design (model CED1401; Cambridge, UK) analog-to-
digital converter interfaced with a personal computer. For
on-line and off-line analyses, Spike 2 data-acquisition soft-
ware was used.
Drugs and drug administration. Drugs were administered
by application of microiontophoretic ejecting currents to the
drug-containing barrels. The drug solutions for microionto-
phoresis were 10 mM AMPA (Tocris Cookson; Bristol, UK),
100 mM NMDA (Sigma; St. Louis, MO), 50 mM NG-nitro-L-
arginine methyl ester (L-NAME, NOS inhibitor; Sigma), 50
mM NG-nitro-D-arginine methyl ester (D-NAME; Sigma), 50
mM 3-[2-hydroxy-2-nitroso-1-propylhydrazino]-1-propana-
mine (PAPA-NONOate or NOC-15, a NO donor; Sigma), and
50 mM hydroxydiazenesulfonic acid 1-oxide disodium salt
(sulfo-NONOate, a negative control of PAPA-NOate; Sigma).
Drugs were dissolved in 150 mM NaCl, and pH was adjusted
to 8.0–8.5 for AMPA and NMDA, 6.5 for L-NAME and D-
NAME, and 8.0 for PAPA-NONOate and sulfo-NONOate. All
drugs were ejected as anions. Retaining currents of appro-
priate polarity were applied to the drug barrels to retain the
passive diffusion of the drug from the electrode tip during
nonejection periods.
NO modulation of EAA responses was studied as follows:
after the baseline spontaneous discharge rate was recorded,
VN-evoked neurons were excited by pulsatile iontophoretic
application of 10–20 nA of NMDA or AMPA (control) until a
steady-state level of evoked discharge was reached. NMDA
and AMPA were ejected for successive 7- to 8-s periods
separated by 10- to 15-s intervals (Fig. 1). At this point, the
iontophoresis of the excitatory agents was stopped, and a
continuous iontophoretic ejection of L-NAME, PAPA-NONO-
ate, or the respective enantiomer was begun. After 2 min,
the pulsatile application of AMPA or NMDA was begun
again. After the AMPA- or NMDA-evoked discharge reached
a steady state, iontophoresis of the excitatory agent and
either the L-NAME, PAPA-NONOate, or the respective en-
antiomer was stopped. After a 3- to 5-min recovery period,
the pulsatile application of AMPA or NMDA was begun again
to determine whether altered responses had returned to
control levels. To examine NO modulation of synaptic inputs,
poststimulus time histograms of 30 responses to 0.5-Hz VN
stimulation were obtained before, during, and after ionto-
phoresis of L-NAME.
Data analysis. Neuronal responses to iontophoretic appli-
cation of NMDA and AMPA were obtained by subtracting the
number of APs during the drug ejection period from the
number of APs measured during an equivalent-duration
baseline period. The number of APs was counted during a
10-s period that began with the onset of the iontophoretic
ejection pulse. AMPA- and NMDA-evoked discharges were
averaged over three or four cycles once the level of discharge
had reached the steady state. AMPA- and NMDA-evoked
discharges are presented as absolute numbers of APs. Rate-
meter records (no. of APs/s) were used for statistical analysis
of the spontaneous discharge rate, and these data are pre-
sented as a frequency (in Hz). All data were analyzed by
repeated-measures ANOVA and subsequent Student’s mod-
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ified t-test with Student-Newman-Keuls test. Significance
was accepted at a 0.05 confidence level.
RESULTS
General characteristics of neurons studied. Success-
ful recordings were obtained from 42 VN-evoked neu-
rons in 26 rats. The average onset latency for VN-
evoked excitation was 2.5  0.2 ms. In 8 neurons, the
vagal afferent input exhibited characteristics consis-
tent with a monosynaptic input (onset latency, 2.3 
0.5 ms), whereas in the remaining 34 neurons, the
input appeared to be polysynaptic (onset latency, 2.6 
2.2 ms). There were no differences between these two
groups in any of the parameters examined, and there-
fore they are grouped together in the subsequent anal-
yses. Spontaneous discharge was present in 34 neu-
rons and averaged 1.1  0.2 Hz.
Responses for 17 of the 34 neurons were observed
after injection of 16 g of phenylbiguanide into the
right atrium to discern a thoracic cardiopulmonary site
of origin for the vagal afferent input. Of the 17 neu-
rons, 10 were excited, 5 were inhibited, 1 did not
respond, and 1 responded with an excitatory response
followed by an inhibitory response.
Effects of L-NAME on AMPA- and NMDA-evoked
discharges in VN-evoked NTS neurons. Iontophoresis
of L-NAME (20–80 nA, 2–5 min) did not alter sponta-
neous discharge rates (2.4  0.5 vs. 2.5  0.7 Hz; n 
15). Iontophoresis of L-NAME had no effect on dis-
charge evoked by VN stimulation (no. of APs evoked by
30 stimuli at 0.5 Hz: control, 26 3; during iontophore-
sis of L-NAME, 27  3; n  11).
The number of APs evoked by pulsatile AMPA ion-
tophoresis was reduced during coiontophoresis of L-
NAME (Fig. 1). For the population, AMPA-evoked dis-
charge was decreased from 44  7 to 29  6 APs (P 
0.002; n  14; Fig. 2). As a control for possible nonspe-
Fig. 1. Rate-meter records of steady-state discharge
evoked by pulsatile iontophoretic application of
(RS)--amino-3-hydroxy-5-methyl-4-isoxazolepropi-
onic acid (AMPA; left) and N-methyl-D-aspartate
(NMDA; right). Traces are arranged with markers of
iontophoretic ejection above rate-meter records of
discharge averaged in 1-s bins. A: steady-state con-
trol responses. B: evoked discharge after a 2-min
period of continuous NG-nitro-L-arginine methyl es-
ter (L-NAME) iontophoresis. C: recovery of evoked
discharge 3 min after cessation of the L-NAME ion-
tophoresis.
Fig. 2. Population responses. A: number of action potentials (APs)
evoked by AMPA before (control), during (L-NAME), and after ces-
sation (recovery) of L-NAME iontophoresis; n  14. *P  0.05,
difference between control and L-NAME. B: number of APs evoked by
NMDA; n  15.
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cific effects of L-NAME, the inactive enantiomer D-
NAME was applied in a manner similar to that de-
scribed for L-NAME. Iontophoresis of D-NAME (40 nA)
did not alter spontaneous discharge (control, 3.0  0.5;
D-NAME, 2.8  0.5 Hz; n  5). In addition, D-NAME
did not alter the number of APs evoked by AMPA
(control, 64  12; D-NAME, 69  9; n  5).
L-NAME did not significantly alter the number of
APs evoked by pulsatile application of NMDA (see Fig.
1). Under control conditions, NMDA iontophoresis
evoked an average of 50  10 APs, and, during ionto-
phoresis of L-NAME, NMDA evoked 45  9 APs (n 
15; Fig. 2).
Although the effects of L-NAME on NMDA-evoked
discharge were not significant for the population, the
iontophoresis of L-NAME caused variable effects on
neurons within the population. The number of NMDA-
evoked APs was reduced by 12–60% during ionto-
phoresis of L-NAME in 6 cells. In 7 cells, NMDA-evoked
discharge changed by only 10% during L-NAME ion-
tophoresis, which was within the normal range of vari-
ability. In 2 cells, L-NAME enhanced NMDA-evoked
discharge by 23 and 50%.
Given the variable effects of L-NAME on NMDA-
evoked discharge, the question arises as to whether
NMDA- and AMPA-evoked discharges were altered in
a similar or dissimilar manner by L-NAME. There was
no relationship between the L-NAME effect on NMDA-
evoked discharge and the L-NAME inhibition of AMPA-
evoked discharge for individual neurons (Fig. 3). In all
neurons, L-NAME decreased responses to AMPA recep-
tor activation regardless of the effect on NMDA-evoked
discharge.
In one neuron, the recording was unusually stable,
and it was possible to examine the effects of L-NAME
over a much broader range of AMPA- and NMDA-
evoked discharges (Fig. 4). Increasing the AMPA or
NMDA iontophoretic ejection current while keeping
duration constant resulted in a dose-related increase in
the number of evoked APs. In this cell, iontophoresis of
L-NAME had no effect on AMPA- or NMDA-evoked
discharges until the EAA-evoked discharge exceeded
150 APs in the 10-s measurement period.
Attempts to overcome L-NAME inhibition with L-
arginine were unsuccessful, because L-arginine ap-
peared to have nonspecific effects on neuronal discharge.
Iontophoresis of L-arginine decreased spontaneous dis-
charge and AMPA-evoked discharge rates in seven of
nine neurons tested with no recovery to the control level
of AMPA-evoked discharge observed after cessation of
the L-arginine iontophoresis.
Effects of PAPA-NONOate on AMPA- and NMDA-
evoked discharges of VN-evoked NTS neurons. In 12
VN-evoked neurons, AMPA-evoked discharge was ex-
amined during iontophoresis of the NO donor PAPA-
NONOate using the same protocol as in the L-NAME
studies. Two cells had no spontaneous discharge before
and during iontophoresis of PAPA-NONOate, and one
cell had an inordinately high spontaneous discharge
rate of 8.8 Hz and was excluded from analysis. The NO
donor increased the spontaneous discharge of six of the
remaining nine cells from a control level of 1.8  3 to
3.2  7 Hz during iontophoresis of PAPA-NONOate
(P  0.03; n  9; Fig. 5A).
Fig. 3. Percent reduction in the number of APs evoked by AMPA vs.
percent change in the number of APs evoked by NMDA during
L-NAME iontophoresis. Each symbol (F) represents an individual
neuron (n  16). Normal range of variability in such evoked re-
sponses, 10%, is indicated (dashed lines).
Fig. 4. Iontophoretic “dose-response”
curves: effects of increasing AMPA (A)
and NMDA (B) iontophoretic ejection
currents on the steady-state number of
evoked APs in the same neuron. Indi-
vidual curves reflect measurements
made before (control), during (L-
NAME), and 3 min after cessation (re-
covery) of L-NAME iontophoresis.
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The number of APs evoked by pulsatile iontophoresis
of AMPA was significantly enhanced during ionto-
phoresis of the NO donor (control, 51  10; during
PAPA-NONOate, 82  16; P  0.04; n  12; Fig. 5B).
Iontophoresis of PAPA-NONOate did not significantly
alter NMDA-evoked discharge (control, 47  8; during
PAPA-NONOate iontophoresis, 51  10; n  5).
As a control for nonspecific effects of PAPA-NONO-
ate, the effects of the inactive enantiomer sulfo-NONO-
ate were examined. Sulfo-NONOate did not alter the
rate of spontaneous discharge (control, 0.8 0.4; sulfo-
NONOate, 0.7  0.4 Hz) or the number of APs evoked
by AMPA application (control, 46  14; during sulfo-
NONOate iontophoresis, 48  14; n  6).
DISCUSSION
This study shows that AMPA receptor-mediated ex-
citation of NTS neurons that receive vagal afferent
inputs can be facilitated by NO. Inhibition of NOS by
L-NAME significantly decreased the number of APs
evoked by AMPA receptor stimulation. The NO donor
PAPA-NONOate significantly enhanced the rate of
spontaneous discharge and the number of APs evoked
by AMPA. The inhibition of NOS by L-NAME did not
significantly decrease the number of APs evoked by
NMDA receptor stimulation when measured for the
population as a whole. In the majority of NTS neurons,
NMDA-evoked discharge was not altered by inhibition
of NOS. However, there was a small number of neurons
in which NMDA-evoked discharge was either facili-
tated or attenuated during iontophoresis of L-NAME.
Reciprocal effects of NO on AMPA- vs. NMDA-evoked
discharge have been reported for the spinal cord dorsal
horn (2).
In the present study, iontophoresis of L-NAME de-
creased the number of APs evoked by AMPA receptor
stimulation in all neurons tested, but the number of
APs evoked by NMDA receptor activation was de-
creased in 40% of the cells. This result was surprising,
because the relationship between NO and NMDA re-
ceptors has been studied in other systems, where it has
been shown that NMDA receptor activation results in
an entrance of Ca2 into the cell that activates NOS
and reduces subsequent NMDA-evoked responses (11,
17, 27). Such an inhibitory feedback mechanism oper-
ating during prolonged activation of NMDA receptors
could be a protective mechanism against glutamate-
induced neurotoxicity (39). It is possible that the timing
of administration or the concentration of NO donors and
NOS inhibitors during iontophoretic application might
explain why we observed variable changes in NMDA-
evoked discharge during the L-NAME treatment. Sensi-
tivity to NO may vary in different populations of cells
(39). Therefore, interactions between NMDA receptors
and NO in the NTS might be related to the specific reflex
function(s) of a given cell.
The role of ionotropic glutamate receptors (NMDA
and non-NMDA) in the integration of visceral afferent
inputs within the NTS has been well demonstrated (1,
3, 8, 15, 33, 35, 36, 44). Many observations also suggest
a role for NO within the NTS in cardiovascular regu-
lation. Intravenous administration of L-NAME reduced
the vasodilation in the hindquarter bed caused by
glutamate microinjection into the NTS (4), which sug-
Fig. 5. Responses to nitric oxide (NO) do-
nor. A: rate-meter record of response of a
neuron to iontophoresis of the NO donor
3-[2-hydroxy-2-nitroso-1-propylhydrazino]-
1-propanamine (PAPA-NONOate) during
the period indicated by the horizontal bar.
Absence of discharge at the end of the
PAPA-NONOate iontophoresis period is the
result of a switching artifact. B: number of
APs evoked by AMPA before (control), dur-
ing (PAPA-NONOate), and after cessation
(recovery) of PAPA-NONOate iontophore-
sis; n  12. *P  0.05.
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gests modulation of glutamatergic excitation by nitroxi-
dergic mechanisms within the NTS. Other in vivo studies
showed that microinjection of L-arginine reduced heart
rate, renal sympathetic nerve activity (RSNA), and blood
pressure, whereas microinjection of a NOS inhibitor in-
creased RSNA and blood pressure (43). These effects may
be dependent on ionotropic glutamate receptors, because
the microinjection of NMDA and non-NMDA receptor
antagonists decreased the effects of L-arginine (20).
Visceral afferent inputs to the NTS can generate NO,
and this NO may modulate afferent integration in the
dorsal vagal complex and autonomic reflex function
(18, 34). Vagal afferents and terminals that contain
nNOS are present in the NTS, and deafferentation of
VN fibers causes a reduction in NOS staining in the
NTS (16, 23, 34, 42). The differential distribution of
nNOS in the NTS supports the idea of NO modulation
of autonomic reflexes (22). The presence of NOS immu-
noreactivity colocalized with NMDA receptor subunit
NMDAR1 and AMPA receptor subunit GluR1 in the
NTS of the rat suggests a modulatory role of NOS
activity on EAA receptor activation (43). The subunits
NMDAR1 and GluR1 are mainly localized on postsyn-
aptic structures, and our study observed the postsyn-
aptic discharge evoked by stimulation of these recep-
tors on NTS neurons.
Our studies cannot definitively determine whether
NO modulates EAA-evoked responses at presynaptic
and/or postsynaptic sites. Our results suggest that this
modulation can occur at a postsynaptic site, because
our protocol examined effects of direct application of
EAA agonists independently of synaptic inputs. How-
ever, NO-stimulated release of glutamate might con-
tribute to the enhanced spontaneous discharge rate
observed during iontophoresis of the NO donor in our
study. The administration of NO via microdialysis in-
duced glutamate release, whereas NOS inhibition re-
duced the basal level of glutamate in the NTS (19). A
recent study demonstrated a facilitatory effect of NO
on the release of glutamate when NMDA receptors
were stimulated in the NTS, which enhanced the hy-
potension and bradycardia that is normally observed
during activation of NMDA receptors in NTS (30).
Therefore, although our data suggest a postsynaptic
site for NO-EAA interactions, it does not preclude
presynaptic interactions.
The lack of inhibition of VN-evoked discharge during
iontophoresis of L-NAME was surprising to us, as we
predicted that NO would modulate synaptic inputs.
However, the lack of inhibition is likely the result of
our protocol. We examined VN-evoked discharge using
a low stimulus frequency, 0.5 Hz. We speculate on the
basis of data obtained from the cell illustrated in Fig. 4
that NO may be of functional importance during peri-
ods of high-frequency discharge, and our VN stimulus
paradigm did not evoke high-frequency discharge. Sim-
ilarly, we failed to observe a reduction in spontaneous
discharge rate during iontophoresis of the NOS inhib-
itor, whereas two previous studies of NTS neurons
have shown such a reduction (26, 41). This difference
could be explained by the relative discharge frequen-
cies of the NTS neurons. In the present study, sponta-
neous discharge was low (1–3 Hz), whereas in the
study of Ma et al. (26), spontaneous discharge fre-
quency was 5–6 Hz. Absolute frequencies were not
reported in the study of Tagawa et al. (41). The in-
crease in spontaneous discharge that was observed
during iontophoresis of the NO donor could be the
result of modulation of synaptic inputs; however, it
could also be the result of changes in postsynaptic
excitability.
The decrease in the number of APs evoked by AMPA
during NOS inhibition suggests that NO facilitates
AMPA transmission within the NTS. Consistent with
this, we observed a significant increase in the number
of APs evoked by AMPA microiontophoresis in the
presence of the NO donor PAPA-NONOate. This com-
pound is considered to be a pure NO donor in that it
releases only NO (40) and does not release other sub-
stances that could interfere with the neuron or affect
NOS activity. Our data reinforce the hypothesis that
AMPA receptor-evoked excitation can be facilitated by
NO. The lack of effect on low-frequency VN-evoked
discharges and the dose-response relationship ob-
tained from one neuron suggest that this facilitation
may only come into play when the neuron is driven into
a high-discharge-frequency state. This would provide a
means of sustaining excitatory transmission rate dur-
ing periods when transmitter depletion or other factors
might otherwise reduce excitation.
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